Partner With the Proven iPSC Experts
By combining top-tier iPSC-derived cells, deep iPSC technology and application expertise, and excellent customer service, Ncardia helps you make more confident decisions and accelerate the development of breakthrough therapies.
Start a ConversationBy continually innovating with human induced pluripotent stem cells (iPSC) technology and diving deep on its applications, we have established a portfolio of relevant cell models, screening assays and custom iPSC services to support the development of new drug, gene and cell therapies.
Physiologically relevant and fully functional cell models, manufactured to scale and readily available.
Human iPSC-based platforms combining physiologically relevant models with robust and scalable assays to help you select the best drug candidates.
These cells provide a convenient, timesaving solution for a wide range of cardiac functional assays. Whether you’re performing drug screening, assay optimization or disease modeling, Ncyte® Plate-ready vCardiomyocytes provide reliable, reproducible results.
Get an exclusive look at next-generation approaches for greater confidence in preclinical testing, including Ncardia’s first-of-its-kind Ncyte® NHP-C vCardiomyocytes.
Are you ready to confidently advance your therapeutic candidates?
Start a Conversation